Hicklin DJ - Search Results

1

Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.

Zebrowski BK, Yano S, Liu W, Shaheen RM, Hicklin DJ, Putnam JB Jr, Ellis LM. Zebrowski BK, et al. Among authors: hicklin dj. Clin Cancer Res. 1999 Nov;5(11):3364-8. Clin Cancer Res. 1999. PMID: 10589746

2

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

Hicklin DJ, Ellis LM. Hicklin DJ, et al. J Clin Oncol. 2005 Feb 10;23(5):1011-27. doi: 10.1200/JCO.2005.06.081. Epub 2004 Dec 7. J Clin Oncol. 2005. PMID: 15585754 Review.

3

Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.

Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM. Wey JS, et al. Among authors: hicklin dj. Cancer. 2005 Jul 15;104(2):427-38. doi: 10.1002/cncr.21145. Cancer. 2005. PMID: 15952180 Free article.

4

Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.

Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ, Ellis LM. Yang AD, et al. Among authors: hicklin dj. Cancer Res. 2006 Jan 1;66(1):46-51. doi: 10.1158/0008-5472.CAN-05-3086. Cancer Res. 2006. PMID: 16397214

5

Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.

Camp ER, Yang A, Liu W, Fan F, Somcio R, Hicklin DJ, Ellis LM. Camp ER, et al. Among authors: hicklin dj. Clin Cancer Res. 2006 Apr 15;12(8):2628-33. doi: 10.1158/1078-0432.CCR-05-2257. Clin Cancer Res. 2006. PMID: 16638876

6

VEGF-targeted therapy: mechanisms of anti-tumour activity.

Ellis LM, Hicklin DJ. Ellis LM, et al. Among authors: hicklin dj. Nat Rev Cancer. 2008 Aug;8(8):579-91. doi: 10.1038/nrc2403. Epub 2008 Jul 3. Nat Rev Cancer. 2008. PMID: 18596824 Review.

7

Pathways mediating resistance to vascular endothelial growth factor-targeted therapy.

Ellis LM, Hicklin DJ. Ellis LM, et al. Among authors: hicklin dj. Clin Cancer Res. 2008 Oct 15;14(20):6371-5. doi: 10.1158/1078-0432.CCR-07-5287. Clin Cancer Res. 2008. PMID: 18927275 Review.

8

Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.

Zhang L, Yu D, Hicklin DJ, Hannay JA, Ellis LM, Pollock RE. Zhang L, et al. Among authors: hicklin dj. Cancer Res. 2002 Apr 1;62(7):2034-42. Cancer Res. 2002. PMID: 11929822

9

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.

Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM. Bruns CJ, et al. Among authors: hicklin dj. Cancer. 2000 Aug 1;89(3):488-99. Cancer. 2000. PMID: 10931447

10

Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis.

Shaheen RM, Tseng WW, Vellagas R, Liu W, Ahmad SA, Jung YD, Reinmuth N, Drazan KE, Bucana CD, Hicklin DJ, Ellis LM. Shaheen RM, et al. Among authors: hicklin dj. Int J Oncol. 2001 Feb;18(2):221-6. Int J Oncol. 2001. PMID: 11172585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters